Extracorporeal Membrane Oxygenation

The subset of patients with high-risk pulmonary embolism who had hemodynamic collapse had an in-hospital mortality rate of 42%, according to a retrospective analysis of a large registry.

Healio Pulmonology has compiled the top news on COVID-19 posted in 2023.

Time to successful weaning off of extracorporeal membrane oxygenation was similar for prone and supine positioning among patients with severe acute respiratory distress syndrome, according to results published in JAMA.

HONOLULU — 2020 COVID-19 hospitalizations requiring extracorporeal membrane oxygenation cost significantly more and had lengthier stays than those that did not utilize ECMO, according to study results presented at the CHEST Annual Meeting.

Obesity reduced the odds for ICU mortality among patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation, according to results published in American Journal of Respiratory and Critical Care Medicine.

Patients with COVID-19-related acute respiratory distress syndrome undergoing transplantation had comparable, high survival rates to patients with COVID-19-related pulmonary fibrosis, according to results published in JAMA Surgery.

In patients with acute MI complicated by cardiogenic shock, use of early extracorporeal life support did not reduce risk for death at 30 days compared with medical therapy alone, researchers reported.

Low chances for extracorporeal membrane oxygenation treatment were found in women, those with Medicaid insurance and those residing in low-income areas, according to results published in Annals of the American Thoracic Society.

Abbott announced FDA clearances for two components of the company’s life support system.

Patients with refractory asthma exacerbations with respiratory failure treated with extracorporeal membrane oxygenation had decreased odds for death compared with standard care, according to study results published in CHEST.